Phase 1 Autoimmune Thrombocytopenia Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

IASO-782 in Autoimmune Hematological Diseases

Autoimmune ThrombocytopeniaWarm Autoimmune Haemolytic Anaemia

Shanghai IASO Biotechnology Co., Ltd16 enrolled2 locationsNCT06534021

Recruiting

Phase 1

Inaticabtagene Autoleucel Injection in the Treatment of Refractory Systemic Lupus Erythematosus-related Immune Thrombocytopenia

Autoimmune Thrombocytopenia

Juventas Cell Therapy Ltd.12 enrolled1 locationNCT06826430